RIGL Projected Dividend Yield
Com Par $0.001/Rigel Pharmaceuticals Inc ( NASDAQ : RIGL )Rigel Pharmaceuticals, Inc. is a biotechnology company. Co. is engaged in developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. It is focused on products that address signaling pathways that are critical to disease mechanisms. Its first product is TAVALISSE (fostamatinib disodium hexahydrate) tablets, the approved oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. 21 YEAR PERFORMANCE RESULTS |
RIGL Dividend History Detail RIGL Dividend News RIGL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |